Cargando…
A New Approach to Understanding Cancer-Related Fatigue: Leveraging the 3P Model to Facilitate Risk Prediction and Clinical Care
SIMPLE SUMMARY: For the growing number of cancer survivors worldwide, fatigue presents a major hurdle to function and quality of life. Treatment options for cancer-related fatigue are still emerging, and our current understanding of its etiology is limited. In this paper, we describe a new applicati...
Autores principales: | Sleight, Alix G., Crowder, Sylvia L., Skarbinski, Jacek, Coen, Paul, Parker, Nathan H., Hoogland, Aasha I., Gonzalez, Brian D., Playdon, Mary C., Cole, Steven, Ose, Jennifer, Murayama, Yuichi, Siegel, Erin M., Figueiredo, Jane C., Jim, Heather S. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027717/ https://www.ncbi.nlm.nih.gov/pubmed/35454890 http://dx.doi.org/10.3390/cancers14081982 |
Ejemplares similares
-
A Molecular Approach to Understanding the Role of Diet in Cancer-Related Fatigue: Challenges and Future Opportunities
por: Crowder, Sylvia L., et al.
Publicado: (2022) -
Use of a Cancer Registry to Evaluate Patient-Reported Outcomes of Immune Checkpoint Inhibitors
por: Jim, Heather S. L., et al.
Publicado: (2020) -
Patient-Reported Outcomes as Interradiographic Predictors of Response in Non–Small Cell Lung Cancer
por: Bhatt, Ambika S., et al.
Publicado: (2023) -
Alcohol and prescription drug safety in older adults
por: Zanjani, Faika, et al.
Publicado: (2013) -
QUALITY OF LIFE IN OLDER ADULTS RECEIVING IMMUNE CHECKPOINT INHIBITOR THERAPY
por: Hoogland, Aasha I, et al.
Publicado: (2019)